MedImmune, the global biologics arm of AstraZeneca, announced today that it has been awarded LEED® Gold building certification established by the U.S. Green Building Council (USGBC) and verified by the Green Building Certification Institute (GBCI). Two facilities, the 308,000 square-foot R&D laboratory and 9,800-square-foot fitness center, received the certification. LEED – Leadership in Energy and Environmental Design – is the nation’s preeminent program for design, construction and operation of high performance green buildings.
“We’re very proud to achieve LEED Gold certification. MedImmune is committed to environmental sustainability and strives to be a good corporate citizen and neighbor to surrounding communities,” said Andy Skibo, Executive Vice President, Operations, MedImmune.